122 related articles for article (PubMed ID: 36197047)
1. Use of Cytokeratin 17 in the Differentiation Between Desmoplastic Trichilemmoma and Cutaneous Basal Cell Carcinoma.
Chaudet KM; Stagner AM; Nazarian RM
Am J Dermatopathol; 2022 Dec; 44(12):886-890. PubMed ID: 36197047
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 17 is highly sensitive in discriminating cutaneous lymphadenoma (a distinct trichoblastoma variant) from basal cell carcinoma.
Goyal A; Solus JF; Chan MP; Doyle LA; Schaffer A; Thakuria M; Horn TD; Duncan LM; Nazarian RM
J Cutan Pathol; 2016 May; 43(5):422-9. PubMed ID: 26968559
[TBL] [Abstract][Full Text] [Related]
3. BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.
Linskey KR; Gimbel DC; Zukerberg LR; Duncan LM; Sadow PM; Nazarian RM
Arch Pathol Lab Med; 2013 Nov; 137(11):1591-8. PubMed ID: 24168496
[TBL] [Abstract][Full Text] [Related]
4. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
Bartoš V
Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma.
Illueca C; Monteagudo C; Revert A; Llombart-Bosch A
J Cutan Pathol; 1998 Sep; 25(8):435-9. PubMed ID: 9826169
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 17: an adjunctive marker of invasion in squamous neoplastic lesions of the anus.
Nazarian RM; Primiani A; Doyle LA; Linskey KR; Duncan LM; Odze RD; Zukerberg LR
Am J Surg Pathol; 2014 Jan; 38(1):78-85. PubMed ID: 24335642
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins.
Anderson-Dockter H; Clark T; Iwamoto S; Lu M; Fiore D; Falanga JK; Falanga V
Dermatol Surg; 2012 Aug; 38(8):1357-66. PubMed ID: 22691048
[TBL] [Abstract][Full Text] [Related]
8. Basaloid neoplasms in nevus sebaceus.
Kaddu S; Schaeppi H; Kerl H; Soyer HP
J Cutan Pathol; 2000 Aug; 27(7):327-37. PubMed ID: 10917159
[TBL] [Abstract][Full Text] [Related]
9. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin.
East E; Fullen DR; Arps D; Patel RM; Palanisamy N; Carskadon S; Harms PW
Am J Dermatopathol; 2016 Oct; 38(10):744-50. PubMed ID: 27043336
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
12. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
[TBL] [Abstract][Full Text] [Related]
13. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery.
Merritt BG; Snow SN; Longley BJ
Cutis; 2010 May; 85(5):254-8. PubMed ID: 20540416
[TBL] [Abstract][Full Text] [Related]
14. Pseudocarcinomatous hyperplasia with follicular differentiation overlying basal cell carcinoma.
Tuttle MS; Rosenberg AS; Winfield HL; Somach SC
Am J Dermatopathol; 2009 Aug; 31(6):557-60. PubMed ID: 19590419
[TBL] [Abstract][Full Text] [Related]
15. Trichilemmoma arising in the nasal vestibule: report of three cases with special emphasis on the differential diagnosis.
Herráiz M; Martín-Fragueiro LM; Tardío JC
Head Neck Pathol; 2012 Dec; 6(4):492-5. PubMed ID: 22669747
[TBL] [Abstract][Full Text] [Related]
16. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
Yu L; Galan A; McNiff JM
J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
[TBL] [Abstract][Full Text] [Related]
17. Cervical Adenoid Basal Carcinoma: Clinicopathologic Features of 9 Cases With Reference to CK17 and Ki-67 Expression.
Liang Y; Lü B; Zhou C
J Low Genit Tract Dis; 2019 Jan; 23(1):77-81. PubMed ID: 30106815
[TBL] [Abstract][Full Text] [Related]
18. Basaloid Carcinoma of the Breast Mimicking Cutaneous Basaloid Neoplasms.
Solus JF; Goyal A; Duncan LM; Nazarian RM
Am J Dermatopathol; 2015 Sep; 37(9):e102-6. PubMed ID: 25229570
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma arising in association with desmoplastic trichilemmoma.
Crowson AN; Magro CM
Am J Dermatopathol; 1996 Feb; 18(1):43-8. PubMed ID: 8721590
[TBL] [Abstract][Full Text] [Related]
20. Basal cell carcinoma with thickened basement membrane: a variant that resembles some benign adnexal neoplasms.
El-Shabrawi L; LeBoit PE
Am J Dermatopathol; 1997 Dec; 19(6):568-74. PubMed ID: 9415612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
